Robert Henry Yarber, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 618 Pegram Dr, Tupelo, MS 38801 Phone: 662-844-6513 Fax: 662-844-1113 |
Dr. Matthew Scott Stevens, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 618 Pegram Dr., Tupelo, MS 38801 Phone: 662-844-6513 Fax: 662-844-1113 |
Dr. Harold Keelen Hudson, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 1488 Columbine Dr, Tupelo, MS 38801 Phone: 662-842-1936 |
Ryan Curtis Simmons, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 618 Pegram Dr, Tupelo, MS 38801 Phone: 662-844-7540 Fax: 662-844-1113 |
James R. Mcauley, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 618 Pegram Dr, Tupelo, MS 38801 Phone: 662-844-6513 Fax: 662-844-1113 |
James Montgomery Berry, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 618 Pegram Dr, Tupelo, MS 38801 Phone: 662-844-6513 Fax: 662-844-1113 |
Kurt Lindsley Nelson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 618 Pegram Dr, Tupelo, MS 38801 Phone: 662-844-6513 |
Malcolm Deaton Mcauley, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 618 Pegram Dr, Tupelo, MS 38801 Phone: 662-844-6513 Fax: 662-844-1113 |
News Archive
The U.S. Food and Drug Administration has approved the first generic versions of Coreg (carvedilol). Coreg is a widely used medication that is FDA-approved to treat high blood pressure, mild to severe chronic heart failure and left ventricular dysfunction following a heart attack.
The U.S. Food and Drug Administration today approved Berinert, the first treatment for acute abdominal attacks and facial swelling associated with a rare and potentially life-threatening genetic disease called hereditary angioedema (HAE).
While stem-cell therapy offers great promise for the treatment of stroke, much research remains to be done to show its long-term effectiveness and to understand the potential for dangerous side effects.
Women who undergo fertility therapy, but do not get pregnant, have a higher risk of developing long-term cardiovascular disease, compared with women who become pregnant, according to a new study published in CMAJ.
G-CON today announced the completed delivery and installation of the ground-breaking POD system in PaxVax's licensed GMP production facility based in San Diego, California where PaxVax manufactures innovative and socially responsible oral vaccines against infectious diseases.
› Verified 6 days ago